PLGF VALUES IN SCREENING FOR PREECLAMPSIA DURING THE FIRST TRIMESTER OF PREGNANCY

Dung Lê Thị Mai, Khuê Nguyễn Thy, Ngân Lê Thị Thu, Hằng Phan Thị, Dung Đặng Ngọc Yến, Tuyết Trương Thị Ánh, Phúc Phạm Nguyễn Hữu, Huân Phạm Nguyên, Huyền Hứu Thị Mỹ, An Phù Thị, Tuyền Bùi Thị Kim, Nhung Nguyễn Thị Hồng, Ngọc Lê Thị Mỹ, Tú Lê Huỳnh Cẩm, Ngân Nguyễn Thị Kim, Niêm Lâm Vĩnh

Main Article Content

Abstract

Objective: Evaluation of PlGF concentration and median value at 11, 12, and 13 weeks of gestation and assess the abnormality rate of PlGF in the first trimester of pregnancy. Subjects and Methods: Pregnant women between 11 and 13 weeks and 6 days of gestation were indicated to undergo PlGF testing as part of the preeclampsia risk screening program from February 2025 to May 2025 at Hung Vuong Hospital in Ho Chi Minh City. Serum samples were collected and PlGF was quantified on the Roche - Cobas e801 system using electrochemiluminescence technology. Data were analyzed using IBM SPSS Statistics 27. Results: The median PlGF and interquartile range (IQR) for gestational weeks 11, 12, and 13 were 40.80 pg/ml (32.20 – 52.30), 51.40 pg/ml (38.10 – 65.75), and 68.10 pg/ml (49.68 – 79.13), respectively. There was no significant difference in median MoM PlGF among maternal age groups. The rates of cases with low PlGF according to the thresholds MoM < 0.3, MoM < 0.4, and MoM < 0.5 were 1.36%, 4.47%, and 10.10%, respectively, with no significant differences in these rates among maternal age and among gestational age groups. Conclusion: PlGF levels increase progressively from week 11 to week 13 of pregnancy. There is a difference in the median PlGF values between Vietnamese pregnant women and other Asian ethnicities. The proportion of pregnant women with MoM PlGF < 0.5 is approximately 10%, evenly distributed across gestational weeks and maternal age groups.

Article Details

References

1. Al‐Rubaie ZTA, Askie LM, Ray JG, et al. The Performance of Risk Prediction Models for Pre‐eclampsia Using Routinely Collected Maternal Characteristics and Comparison With Models That Include Specialised Tests and With Clinical Guideline Decision Rules: A Systematic Review. Bjog an International Journal of Obstetrics & Gynaecology. 2016;123(9):1441-1452.
2. Benschop L, Schalekamp‐Timmermans S, Broere-Brown ZA, et al. Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy. Circulation. 2019;139(14): 1698-1709.
3. Bộ Y tế. Quyết định số 1911/QĐ-BYT. Quyết định về việc ban hành tài liệu hướng dẫn sàng lọc và điều trị dự phòng tiền sản giật. 2021: 5-9.
4. Cavoretto PI, Salmeri N, Candiani M, et al. Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study. Ultrasound in Obstetrics & Gynecology. 2023;61(4):474-480.
5. Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. American Journal of Obstetrics & Gynecology. 2022;226(2):S1071-S1097.e2.
6. Ng QJ, Han JY, Saffari SE, et al. Longitudinal circulating placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in Asian women: a prospective cohort study. BMJ Open. 2019;9(5):e028321.
7. Nurdiati DS, Kusuma A, Al Fattah AN, et al. Reference range of placental growth factors at 11–14 weeks’ gestation in Indonesia. Placenta. 2024;145:126-129.
8. Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2019;145 Suppl 1(Suppl 1):1-33.